A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis.

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2024
This article has no abstract
Epistemonikos ID: 8449c44e4eaea1fb6be9cb28e85e4249bd802348
First added on: Apr 11, 2025